Hologic Debt to Equity Ratio 2010-2025 | HOLX
Current and historical debt to equity ratio values for Hologic (HOLX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Hologic debt/equity for the three months ending March 31, 2025 was 0.54.
| Hologic Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $3.93B | $4.62B | 0.85 |
| 2024-12-31 | $3.96B | $4.77B | 0.83 |
| 2024-09-30 | $4.03B | $5.13B | 0.79 |
| 2024-06-30 | $3.94B | $4.95B | 0.80 |
| 2024-03-31 | $3.87B | $4.84B | 0.80 |
| 2023-12-31 | $3.82B | $4.65B | 0.82 |
| 2023-09-30 | $4.12B | $5.02B | 0.82 |
| 2023-06-30 | $4.16B | $5.18B | 0.80 |
| 2023-03-31 | $4.15B | $5.30B | 0.78 |
| 2022-12-31 | $4.20B | $5.09B | 0.82 |
| 2022-09-30 | $4.20B | $4.88B | 0.86 |
| 2022-06-30 | $4.36B | $5.00B | 0.87 |
| 2022-03-31 | $4.72B | $4.79B | 0.99 |
| 2021-12-31 | $4.77B | $4.52B | 1.06 |
| 2021-09-30 | $4.70B | $4.22B | 1.11 |
| 2021-06-30 | $4.71B | $3.88B | 1.22 |
| 2021-03-31 | $4.25B | $3.80B | 1.12 |
| 2020-12-31 | $4.28B | $3.27B | 1.31 |
| 2020-09-30 | $4.49B | $2.71B | 1.66 |
| 2020-06-30 | $4.55B | $2.26B | 2.01 |
| 2020-03-31 | $4.73B | $2.09B | 2.26 |
| 2019-12-31 | $4.05B | $2.26B | 1.80 |
| 2019-09-30 | $4.33B | $2.12B | 2.05 |
| 2019-06-30 | $4.31B | $2.22B | 1.94 |
| 2019-03-31 | $4.37B | $2.16B | 2.02 |
| 2018-12-31 | $4.54B | $2.39B | 1.90 |
| 2018-09-30 | $4.80B | $2.43B | 1.98 |
| 2018-06-30 | $4.64B | $2.45B | 1.90 |
| 2018-03-31 | $4.79B | $2.45B | 1.96 |
| 2017-12-31 | $4.85B | $3.19B | 1.52 |
| 2017-09-30 | $5.20B | $2.79B | 1.87 |
| 2017-06-30 | $5.25B | $2.87B | 1.83 |
| 2017-03-31 | $5.91B | $2.80B | 2.11 |
| 2016-12-31 | $5.11B | $2.23B | 2.29 |
| 2016-09-30 | $5.17B | $2.14B | 2.42 |
| 2016-06-30 | $5.26B | $2.04B | 2.58 |
| 2016-03-31 | $5.24B | $2.04B | 2.56 |
| 2015-12-31 | $5.51B | $2.17B | 2.55 |
| 2015-09-30 | $5.56B | $2.08B | 2.68 |
| 2015-06-30 | $5.89B | $2.24B | 2.63 |
| 2015-03-31 | $5.86B | $2.17B | 2.70 |
| 2014-12-31 | $5.98B | $2.10B | 2.84 |
| 2014-09-30 | $6.35B | $2.06B | 3.08 |
| 2014-06-30 | $6.38B | $2.03B | 3.14 |
| 2014-03-31 | $6.38B | $1.98B | 3.22 |
| 2013-12-31 | $6.53B | $1.95B | 3.35 |
| 2013-09-30 | $7.06B | $1.94B | 3.64 |
| 2013-06-30 | $7.34B | $3.00B | 2.45 |
| 2013-03-31 | $7.32B | $2.99B | 2.45 |
| 2012-12-31 | $7.48B | $2.98B | 2.51 |
| 2012-09-30 | $7.52B | $2.96B | 2.54 |
| 2012-06-30 | $3.02B | $3.00B | 1.01 |
| 2012-03-31 | $3.07B | $2.98B | 1.03 |
| 2011-12-31 | $3.08B | $2.96B | 1.04 |
| 2011-09-30 | $3.07B | $2.94B | 1.05 |
| 2011-06-30 | $3.03B | $2.91B | 1.04 |
| 2011-03-31 | $2.98B | $2.86B | 1.04 |
| 2010-12-31 | $2.91B | $2.75B | 1.06 |
| 2010-09-30 | $2.93B | $2.70B | 1.09 |
| 2010-06-30 | $2.91B | $2.82B | 1.03 |
| 2010-03-31 | $2.95B | $2.79B | 1.06 |
| 2009-12-31 | $2.93B | $2.76B | 1.06 |
| 2009-09-30 | $2.96B | $2.73B | 1.09 |
| 2009-06-30 | $3.26B | $2.46B | 1.33 |
| 2009-03-31 | $3.38B | $2.40B | 1.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $14.255B | $4.030B |
| Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.611B | 79.98 |
| Thermo Fisher Scientific (TMO) | United States | $148.189B | 17.92 |
| Edwards Lifesciences (EW) | United States | $43.397B | 28.45 |
| Alcon (ALC) | Switzerland | $41.812B | 28.26 |
| IDEXX Laboratories (IDXX) | United States | $41.807B | 48.04 |
| DexCom (DXCM) | United States | $31.765B | 49.10 |
| IQVIA Holdings (IQV) | United States | $26.748B | 14.98 |
| Mettler-Toledo (MTD) | United States | $23.806B | 28.31 |
| STERIS (STE) | Ireland | $23.238B | 25.59 |
| Waters (WAT) | United States | $20.195B | 28.49 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.992B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $10.670B | 30.27 |
| Penumbra (PEN) | United States | $9.953B | 78.12 |
| Masimo (MASI) | United States | $8.825B | 32.55 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.848B | 0.00 |
| Teleflex (TFX) | United States | $5.202B | 8.59 |
| TransMedics (TMDX) | United States | $4.194B | 91.18 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.301B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.463B | 14.67 |
| Veracyte (VCYT) | United States | $2.100B | 29.47 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Alphatec Holdings (ATEC) | United States | $1.592B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.359B | 0.00 |
| Artivion (AORT) | United States | $1.268B | 118.80 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.926B | 4.92 |
| Beta Bionics (BBNX) | United States | $0.771B | 0.00 |
| IRadimed (IRMD) | United States | $0.743B | 37.71 |
| SiBone (SIBN) | United States | $0.711B | 0.00 |
| RxSight (RXST) | United States | $0.564B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.507B | 11.89 |
| Delcath Systems (DCTH) | United States | $0.493B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AxoGen (AXGN) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.406B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.356B | 9.48 |
| NeuroPace (NPCE) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.343B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.286B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Neuronetics (STIM) | United States | $0.222B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.205B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.39 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |